Delayed
TEL AVIV STOCK EXCHANGE
07:24:09 2024-04-25 am EDT
|
5-day change
|
1st Jan Change
|
2,666
ILa
|
-1.26%
|
|
-1.08%
|
-11.13%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,400
|
5,671
|
5,596
|
8,236
|
5,877
|
6,438
|
Enterprise Value (EV)
1 |
6,868
|
9,451
|
10,097
|
13,257
|
12,843
|
13,564
|
P/E ratio
|
12.3
x
|
12.2
x
|
21.6
x
|
7.54
x
|
6.33
x
|
12.9
x
|
Yield
|
5.88%
|
3.53%
|
4.58%
|
4.86%
|
4.25%
|
4.11%
|
Capitalization / Revenue
|
6.96
x
|
10.1
x
|
9.44
x
|
13.4
x
|
8.07
x
|
8.29
x
|
EV / Revenue
|
14.1
x
|
16.9
x
|
17
x
|
21.5
x
|
17.6
x
|
17.5
x
|
EV / EBITDA
|
16.5
x
|
20.3
x
|
20.8
x
|
23.4
x
|
25.3
x
|
21.8
x
|
EV / FCF
|
43.3
x
|
26.3
x
|
-48.2
x
|
42.7
x
|
-80.5
x
|
12.7
x
|
FCF Yield
|
2.31%
|
3.8%
|
-2.08%
|
2.34%
|
-1.24%
|
7.89%
|
Price to Book
|
1.39
x
|
2.09
x
|
2.02
x
|
2.28
x
|
1.48
x
|
1.53
x
|
Nbr of stocks (in thousands)
|
213,676
|
213,676
|
213,757
|
214,480
|
214,485
|
214,593
|
Reference price
2 |
15.91
|
26.54
|
26.18
|
38.40
|
27.40
|
30.00
|
Announcement Date
|
3/19/19
|
2/12/20
|
2/1/21
|
1/31/22
|
1/31/23
|
2/7/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
488.2
|
559.6
|
593
|
615.5
|
728.6
|
777
|
EBITDA
1 |
417.3
|
466.1
|
485.5
|
566.5
|
508
|
622.9
|
EBIT
1 |
414.4
|
461.6
|
481
|
561.7
|
503.1
|
615.6
|
Operating Margin
|
84.88%
|
82.47%
|
81.11%
|
91.27%
|
69.06%
|
79.22%
|
Earnings before Tax (EBT)
1 |
437.2
|
725.2
|
434.4
|
1,616
|
1,443
|
834.4
|
Net income
1 |
276.5
|
463.4
|
260.1
|
1,092
|
929.9
|
499.4
|
Net margin
|
56.63%
|
82.8%
|
43.87%
|
177.5%
|
127.64%
|
64.27%
|
EPS
2 |
1.294
|
2.167
|
1.210
|
5.090
|
4.330
|
2.320
|
Free Cash Flow
1 |
158.6
|
359.4
|
-209.5
|
310.8
|
-159.6
|
1,070
|
FCF margin
|
32.48%
|
64.22%
|
-35.33%
|
50.5%
|
-21.91%
|
137.76%
|
FCF Conversion (EBITDA)
|
38.01%
|
77.1%
|
-
|
54.87%
|
-
|
171.83%
|
FCF Conversion (Net income)
|
57.36%
|
77.56%
|
-
|
28.45%
|
-
|
214.35%
|
Dividend per Share
2 |
0.9360
|
0.9360
|
1.200
|
1.865
|
1.165
|
1.234
|
Announcement Date
|
3/19/19
|
2/12/20
|
2/1/21
|
1/31/22
|
1/31/23
|
2/7/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,469
|
3,780
|
4,501
|
5,021
|
6,966
|
7,126
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.313
x
|
8.11
x
|
9.27
x
|
8.863
x
|
13.71
x
|
11.44
x
|
Free Cash Flow
1 |
159
|
359
|
-210
|
311
|
-160
|
1,070
|
ROE (net income / shareholders' equity)
|
10.8%
|
16.5%
|
9.17%
|
30.7%
|
24%
|
12.8%
|
ROA (Net income/ Total Assets)
|
3.1%
|
3.14%
|
2.87%
|
3.05%
|
2.37%
|
2.57%
|
Assets
1 |
8,919
|
14,753
|
9,075
|
35,872
|
39,173
|
19,416
|
Book Value Per Share
2 |
11.40
|
12.70
|
13.00
|
16.80
|
18.50
|
19.60
|
Cash Flow per Share
2 |
4.680
|
4.160
|
8.020
|
2.160
|
2.470
|
3.570
|
Capex
1 |
2.52
|
7.52
|
1.63
|
4.2
|
10.2
|
14.4
|
Capex / Sales
|
0.52%
|
1.34%
|
0.28%
|
0.68%
|
1.4%
|
1.85%
|
Announcement Date
|
3/19/19
|
2/12/20
|
2/1/21
|
1/31/22
|
1/31/23
|
2/7/24
|
Last Close Price
26.66
ILS Average target price
35
ILS Spread / Average Target +31.28% Consensus |